alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of General Medical Sciences Special Emphasis Panel; Review of the Centers of Biomedical Research Excellence (COBRE) Phase 2 Applications.                    

*Date:*                         February 24-25, 2022.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892 (Video Meeting).                    

*Contact Person:*                         Sonia Ortiz-Miranda, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN18, Bethesda, MD 20892, (301) 402-9448,                         *sonia.ortiz-miranda@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS)

Dated: January 7, 2022.

Miguelina Perez,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-00482 Filed 1-12-22; 8:45 am]

BILLING CODE 4140-01-P
[Federal Register Volume 87, Number 11 (Tuesday, January 18, 2022)]
[Notices]
[Page 2616]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00831]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2021-N-1037]


Fresenius USA, Inc., et al.; Withdrawal of Approval of 216 
Abbreviated New Drug Applications; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of October 22, 2021. The document 
announced the withdrawal of approval of 216 abbreviated new drug 
applications (ANDAs) from multiple applicants, as of November 22, 2021. 
The document was published with an incorrect date. In addition, the 
document indicated that FDA was withdrawing approval of ANDA 075941, 
Strontium Chloride SR-89 Injection, 1 millicurie/milliliter, held by 
Bio-Nucleonics, Inc., 1600 Market St., Suite 13200, Philadelphia, PA 
19103, for repeated failure to submit annual reports. Before FDA 
withdrew the approval of this ANDA, the application holder informed FDA 
that it submitted annual reports for ANDA 075941. Therefore, FDA 
rescinds its withdrawal of approval of ANDA 075941. The approval of 
ANDA 075941 is still in effect.

FOR FURTHER INFORMATION CONTACT: James Hanratty, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 75, Rm. 1671, Silver Spring, MD 20993-0002, 240-
402-4718, <a href="/cdn-cgi/l/email-protection#82c8e3efe7f1accae3ecf0e3f6f6fbc2e4e6e3aceaeaf1ace5edf4"><span class="__cf_email__" data-cfemail="8bc1eae6eef8a5c3eae5f9eafffff2cbedefeaa5e3e3f8a5ece4fd">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:

Corrections

    In the Federal Register of Friday, October 22, 2021 (86 FR 58675), 
in FR Doc. 2021-23075, the following corrections are made:
    1. On page 58675, in the second column, correct the DATES section 
to read: DATES: Approval is withdrawn as of October 22, 2021.''
    2. On page 58679, in the table, remove the entry for ANDA 075941.

    Dated: January 12, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-00831 Filed 1-14-22; 8:45 am]
BILLING CODE 4164-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**Exhibit
      32.1**




**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**








In
      connection with the Quarterly Report on Form 10-Q of Data Systems & Software
      Inc. (the “Company”) for the quarterly period ended March 31, 2006 as filed with
      the Securities and Exchange Commission on the date hereof (the “Report”), I,
      John A. Moore, Chief Executive Officer of the Company, hereby certify, pursuant
      to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
      2002, that:






(1)
            The
                Report fully complies with the requirements of section 13(a) or 15(d)
                of
                the Securities Exchange Act of 1934;
                and






(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and result of operations of the
                Company.




/s**/** John
      A. Moore


John
      A.
      Moore


Chief
      Executive Officer


May
      19,
      2006
<PAGE>


                                                                    EXHIBIT 23.2


                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in the Registration
Statements on Forms S-3 (Nos. 333-45028, 333-66292, 333-53965 and 333-37013) and
on Forms S-8 (Nos. 333-74258, 333-74264, 333-59372, 333-92337, 333-80501,
333-85107 and 333-26015) of Verso Technologies, Inc. (formerly Eltrax Systems,
Inc.) of our report dated February 28, 2000, except for discontinued operations
reclassifications and revisions, the dates for which are July 19, 2000 and March
31, 2002, relating to the financial statements and financial statement schedule,
which appear in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Detroit, Michigan
March 31, 2002
**EXHIBIT 15**

 

Bank of America, N.A. as Trustee  

    for the Cross Timbers Royalty Trust: 

 

We are aware that XTO Energy Inc. and Cross Timbers Royalty Trust have incorporated by reference in Registration Statement No. 333-56983 on Form S-3, and that XTO Energy Inc. has incorporated by reference in itsRegistration Statement Nos. 33-55784 and 333-91460 on Form S-8, Cross Timbers Royalty Trust’s Form 10-Q for the quarter ended September 30, 2003, which includes our report dated October 15, 2003, covering the unaudited interim financialinformation contained therein. Pursuant to Regulation C of the Securities Act of 1933, that report is not considered a part of the registration statement prepared or certified by our firm or a report prepared or certified by our firm within themeaning of Sections 7 and 11 of the Act. 

 

KPMGLLP 

 

Dallas, Texas 

October 17, 2003 ****
<PAGE>   1

                                                                   Exhibit 23.02

                        CONSENT OF INDEPENDNET AUDITORS

We consent to the incorporation by reference in the following registration
statements of RMI.NET, Inc. and in the related prospectuses of our report dated
February 27, 1998, with respect to the consolidated financial statements of
income, stockholders' equity and cash flows for the year ended December 31, 1997
of RMI.NET, Inc. included in this Annual Report (Form 10-K) for the year ended
December 31, 1999:

1.  Registration Statement on Form S-8 (No. 333-30198) pertaining to the Rocky
    Mountain Internet, Inc. 1998 Employees' Stock Option Plan, the Rocky
    Mountain Internet, Inc. 1998 Non-employee Directors' Stock Option Plan, the
    Rocky Mountain Internet, Inc. 1997 Stock Option Plan, the Mary Beth Vitale
    Employment Letter Agreement, the Christopher J. Melcher Employment Letter
    Agreement, and the Michael D. Dingman, Jr. Employment Letter Agreement.

2.  Registration Statement on Post Effective Amendment No. 3 to Form S-1
    Registration Statement filed on Form S-3 (No. 333-52731).

3.  Registration Statement on Post Effective Amendment No. 5 to Form S-1
    Registration Statement filed on Form S-4 (No. 333-52731).



                                     /s/ BAIRD, KURTZ & DOBSON


Denver, Colorado
March 30, 2000
Case 1:00-cr-00093-SAS Document 60 Filed 10/19/2006 Page 1 of 2Case 1:00-cr-00093-SAS Document 60 Filed 10/19/2006 Page 2 of 2
**Exhibit 31.2****Rule 13a-14(a)/15d-14(a) Certification**I, Martin D. Kidder, certify that: 1. I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2006 ofVerso Technologies, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to theperiod covered by this report;  3. Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periodspresented in this report;  4. The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the registrant and have:(a) Designed suchdisclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed underour supervision, to ensure that material informationrelating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within thoseentities, particularly during the period in which thisreport is being prepared;(b) Evaluated theeffectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by thisreport based on such evaluation; and(c) Disclosed in thisreport any change in the registrant’s internal controlover financial reporting that occurred during theregistrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report)that has materially affected, or is reasonably likely tomaterially affect, the registrant’s internal control overfinancial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (or personsperforming the equivalent functions):(a) All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize and reportfinancial information; and(b) Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.Date: April 2, 2007      /s/  Martin D. Kidder
**Exhibit
      23(ii)**







**Consent
      of Independent Registered Public Accounting Firm**













*The
      Board of Directors*


*General
      Electric Capital Services, Inc.:*







We
      consent to the incorporation by reference in the registration statement (No.
      33-7348) on Form S-3 of General Electric Capital Services, Inc., of our report
      dated February 10, 2006, relating to the statement of financial position of
      General Electric Capital Services, Inc. and consolidated affiliates as of
      December 31, 2005 and 2004, and the related statements of earnings, changes
      in
      shareowner’s equity and cash flows for each of the years in the three-year
      period ended December 31, 2005, and related schedule and management’s assessment
      of the effectiveness of internal control over financial reporting as of December
      31, 2005 and the effectiveness of internal control over financial reporting
      as
      of December 31, 2005, which report appears in the December 31, 2005 annual
      report on Form 10-K of General Electric Capital Services, Inc. Our report refers
      to changes in the method of accounting in 2004 and 2003 for variable interest
      entities.













/s/
      KPMG LLP


Stamford,
      Connecticut


March
      3, 2006
[Federal Register Volume 87, Number 14 (Friday, January 21, 2022)]
[Notices]
[Page 3300]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01167]


=======================================================================
-----------------------------------------------------------------------

FEDERAL MARITIME COMMISSION


Notice of Agreement Filed

    The Commission hereby gives notice of the filing of the following 
agreement under the Shipping Act of 1984. Interested parties may submit 
comments, relevant information, or documents regarding the agreement to 
the Secretary by email at <a href="/cdn-cgi/l/email-protection#cc9fa9afbea9b8adbeb58caaa1afe2aba3ba"><span class="__cf_email__" data-cfemail="9ccff9ffeef9e8fdeee5dcfaf1ffb2fbf3ea">[email protected]</span></a>, or by mail, Federal 
Maritime Commission, Washington, DC 20573. Comments will be most 
helpful to the Commission if received within 12 days of the date this 
notice appears in the Federal Register. Copies of agreement are 
available through the Commission's website (www.fmc.gov) or by 
contacting the Office of Agreements at (202)-523-5793 or 
<a href="/cdn-cgi/l/email-protection#681c1a090c0d09060904111b011b280e050b460f071e"><span class="__cf_email__" data-cfemail="651117040100040b04091c160c16250308064b020a13">[email protected]</span></a>.
    Agreement No.: 201376.
    Agreement Name: Tropical/Seaboard Antigua Space Charter Agreement.
    Parties: Tropical Shipping & Construction Co. Ltd.; and Seaboard 
Marine Ltd.
    Filing Party: Wayne Rohde; Cozen O'Connor.
    Synopsis: The Agreement would authorize Tropical to charter space 
to Seaboard in the trade between Palm Beach, FL and ports in Antigua.
    Proposed Effective Date: 2/25/2022.
    Location: https://www2.fmc.gov/FMC.Agreements.Web/Public/AgreementHistory/55502.

    Dated: January 18, 2022.
William Cody,
Secretary.
[FR Doc. 2022-01167 Filed 1-20-22; 8:45 am]
BILLING CODE 6730-02-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 87, Number 15 (Monday, January 24, 2022)]
[Notices]
[Pages 3540-3541]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01215]


=======================================================================
-----------------------------------------------------------------------

FEDERAL TRADE COMMISSION


Revised Jurisdictional Thresholds for Section 8 of the Clayton 
Act

AGENCY: Federal Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Federal Trade Commission announces the revised thresholds 
for interlocking directorates required by the 1990 amendment of Section 
8 of the Clayton Act. Section 8 prohibits, with certain exceptions, one 
person from serving as a director or officer of two competing 
corporations if

[[Page 3541]]

two thresholds are met. Competitor corporations are covered by Section 
8 if each one has capital, surplus, and undivided profits aggregating 
more than $10,000,000, with the exception that no corporation is 
covered if the competitive sales of either corporation are less than 
$1,000,000. Section 8(a)(5) requires the Federal Trade Commission to 
revise those thresholds annually, based on the change in gross national 
product. The new thresholds, which take effect immediately, are 
$41,034,000 for Section 8(a)(1), and $4,103,400 for Section 8(a)(2)(A).

DATES: January 24, 2022.

FOR FURTHER INFORMATION CONTACT: Christopher M. Grengs, (202-326-2612), 
Bureau of Competition, Office of Policy and Coordination.
    Authority: 15 U.S.C. 19(a)(5).

April J. Tabor,
Secretary.
[FR Doc. 2022-01215 Filed 1-21-22; 8:45 am]
BILLING CODE 6750-01-P
I 

111TH CONGRESS 

2D SESSION H. R. 4624 

To designate the facility of the United States Postal Service located at 

125 Kerr Avenue in Rome City, Indiana, as the ‘‘SPC Nicholas Scott 

Hartge Post Office’’. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 9, 2010 

Mr. SOUDER (for himself, Mr. VISCLOSKY, Mr. DONNELLY of Indiana, Mr. 

PENCE, Mr. BURTON of Indiana, Mr. CARSON of Indiana, and Mr. ELLSWORTH) introduced the following bill; which was referred to the Committee on Oversight and Government Reform 

A BILL 

To designate the facility of the United States Postal Service 

located at 125 Kerr Avenue in Rome City, Indiana, 

as the ‘‘SPC Nicholas Scott Hartge Post Office’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SPC NICHOLAS SCOTT HARTGE POST OFFICE. 

4 (a) DESIGNATION.—The facility of the United States 

5 Postal Service located at 125 Kerr Avenue in Rome City, 

6 Indiana, shall be known and designated as the ‘‘SPC Nich7 olas Scott Hartge Post Office’’. 


srobinson on DSKHWCL6B1PROD with BILLS
2 

•HR 4624 IH

1 (b) REFERENCES.—Any reference in a law, map, reg2 ulation, document, paper, or other record of the United 

3 States to the facility referred to in subsection (a) shall 

4 be deemed to be a reference to the ‘‘SPC Nicholas Scott 

5 Hartge Post Office’’. 

Æ 


srobinson on DSKHWCL6B1PROD with BILLS
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

# FEDERAL REGISTER CITATION OF PREVIOUS ANNOUNCEMENT:

 To be published.

# PREVIOUSLY ANNOUNCED TIME AND DATE OF THE MEETING:

 Thursday, January 20, 2022 at 2 p.m.

# CHANGES IN THE MEETING:

 The Closed Meeting scheduled for Thursday, January 20, 2022 at 2 p.m. has been changed to Thursday, January 20, 2022 at 2:15 p.m.

# CONTACT PERSON FOR MORE INFORMATION:

 For further information and to ascertain what, if any, matters have been added, deleted or postponed, please contact Vanessa A. Countryman from the Office of the Secretary at (202) 551-5400.

*Authority:*5 U.S.C. 552b.                    

Dated: January 13, 2022.

Vanessa A. Countryman,

Secretary.

[FR Doc. 2022-01000 Filed 1-14-22; 11:15 am]

BILLING CODE 8011-01-P
EXHIBIT 32.2 

**CERTIFICATION PURSUANT TO****18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the annual report of Globix Corporation (the “Company”) on Form 10-K for the period ending September 30, 2006 as filed with the Securities and Exchange Commission (the “Report”), I,Eric J. Sandman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 

 (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

Dated: December 28, 2006